MFMatheus Cavalcante Franco

Matheus Cavalcante Franco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matheus Cavalcante Franco has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endoscopic ultrasound-guided rendezvous vs precut for difficult biliary cannulation: Updated meta-analysis

    by Dario Quintini, Radhika Chavan, Gabriele Rancatore, Giacomo Emanuele Maria Rizzo, Giuseppe Infantino, Dario Ligresti, Kalpit Devani, Sanjay Lalchandsingh Rajput, Marcelo Cristalli Pacheco da Costa, Matheus Cavalcante Franco, et al.

    Difficult biliary cannulation (DBC) remains a significant challenge in endoscopic retrograde cholangiopancreatography (ERCP). When cannulation fails, precut techniques are widely used as rescue techniques. Endoscopic ultrasound-guided rendezvous (EUS-RV) is increasingly used by experts as an alternative to precut for cannulating the bile duct. However, there is limited literature comparing these two techniques. This systematic review and meta-analysis aimed to compare effectiveness and safety of EUS-RV versus precut techniques for biliary access in DBC. A systematic search was conducted across PubMed, Embase, and Cochrane Library databases up to April 2025. Studies comparing EUS-RV and precut techniques in adult patients with DBC were included. Data were pooled using a random-effects model. Primary outcome was technical success rates; secondary outcome was adverse event (AE) rates. P < 0.05 was considered statistically significant. Five studies (two randomized controlled trials and three retrospective cohorts) comprising 875 patients were included. Pooled technical success was higher with EUS-RV compared with precut (95.9% vs. 91.4%; relative risk [RR] 1.06; 95% confidence interval [CI] 1.00-1.12; P = 0.036). AE rates were 7.7% for EUS-RV and 11.2% for precut, with no statistically significant difference (RR, 0.78; 95% CI 0.46-1.31; P = 0.349). EUS-RV is associated with higher technical success rates compared with precut techniques for rescue biliary cannulation after failed standard ERCP, with a comparable safety profile. These findings suggest that EUS-RV may represent at least a valuable alternative rescue strategy when expertise is available; however, further trials are needed to assess its safety, procedure duration, and learning curve.

  • Open Access

    III BRAZILIAN CONSENSUS STATEMENT ON ENDOSCOPIC ULTRASOUND

    by Ricardo Rangel de Paula Pessoa, Alexandre Moraes Bestetti, Victor Lira de Oliveira, Wladimir Campos de Araujo, Simone Guaraldi, Rodrigo Roda Rodrigues Silva, Francisco Antonio Araujo Oliveira, Maria Sylvia Ierardi Ribeiro, Fred Olavo Aragão Andrade Carneiro, Marco Aurélio D’aSsunção, et al.

    Background: In the past decades, endoscopic ultrasound has developed from a diagnostic tool to a platform for many therapeutic interventions. Various technological advancements have emerged since the last Brazilian Consensus, demanding a review and update of the recommendations based on the best scientific evidence. Methods: A group of 32 renowned echoendoscopists selected eight relevant topics to be discussed to generate clinical questions. After that, a literature review was conducted to answer these questions based on the most updated evidence. Results: Thirty-three statements were formulated and voted on by the experts to reach a consensus. The Oxford System was used to grade the level of evidence. Conclusion: There is moderate evidence to support that the needle shape, gauge, or aspiration technique does not influence the yield of endoscopic ultrasound (EUS)-guided tissue sampling of pancreatic solid lesions. There is moderate evidence to support using EUS-TTNB of the cyst wall to differentiate between mucinous and non-mucinous cystic neoplasms. There is little evidence to support the EUS-guided treatment of gastric varices. There is a high level of evidence to support that EUS-guided biliary drainage and ERCP present similar outcomes in patients with distal malignant biliary obstruction. There is a high level of evidence for using EUS to diagnose neoplastic pancreatic cysts and detect necrosis before indicating drainage. There is moderate evidence to support EUS-GE over duodenal stent for malignant gastric outlet obstruction in patients with a life expectancy higher than 2 months. There is a high level of evidence to support the use of RFA in treating both functioning and non-functioning types of NET.


  • Open Access

    Endoscopic ultrasound-guided gastroenterostomy (gastroenteric anastomosis)

    by Joel Fernandez de Oliveira, Matheus Cavalcante Franco, Gustavo Rodela, Fauze Maluf-Filho, Bruno Costa Martins

    Joel Fernandez de Oliveira, Matheus Cavalcante Franco, Gustavo Rodela, Fauze Maluf-Filho, and Bruno Costa Martins. Int J Gastrointest Interv 2022;11:112-8. https://doi.org/10.18528/ijgii220024


  • Open Access

    Risk Stratification in Cancer Patients with Acute Upper Gastrointestinal Bleeding: Comparison of Glasgow-Blatchford, Rockall and AIMS65, and Development of a New Scoring System

    by Matheus Cavalcante Franco, Sunguk Jang, Bruno da Costa Martins, Tyler Stevens, Vipul Jairath, Rocio Lopez, John J. Vargo, Alan Barkun, Fauze Maluf-Filho

    Background/Aims: Few studies have measured the accuracy of prognostic scores for upper gastrointestinal bleeding (UGIB) among cancer patients. Thereby, we compared the prognostic scores for predicting major outcomes in cancer patients with UGIB. Secondarily, we developed a new model to detect patients who might require hemostatic care.Methods: A prospective research was performed in a tertiary hospital by enrolling cancer patients admitted with UGIB. Clinical and endoscopic findings were obtained through a prospective database. Multiple logistic regression analysis was performed to gauge the power of each score.Results: From April 2015 to May 2016, 243 patients met the inclusion criteria. The AIMS65 (area under the curve [AUC] 0.85) best predicted intensive care unit admission, while the Glasgow-Blatchford score best predicted blood transfusion (AUC 0.82) and the low-risk group (AUC 0.92). All scores failed to predict hemostatic therapy and rebleeding. The new score was superior (AUC 0.74) in predicting hemostatic therapy. The AIMS65 (AUC 0.84) best predicted in-hospital mortality.Conclusions: The scoring systems for prognostication were validated in the group of cancer patients with UGIB. A new score was developed to predict hemostatic therapy. Following this result, future prospective research should be performed to validate the new score.


  • Mo1132 CLINICAL AND ENDOSCOPIC FEATURES OF METASTASES TO THE GASTROINTESTINAL TRACT

    by Luiza H. Bento, Mauricio K. Minata, Clelma Batista Pires, Rodrigo Corsato Scomparin, Luciano Lenz, Marcelo S. de Lima, Bruno da Costa Martins, Carla C. Gusmon, Fabio S. Kawaguti, Caterina Pennacchi, et al.

  • Mo1100 PROPOSED CLINICAL MODEL FOR PREDICTION OF HEMOSTATIC THERAPY FOR UPPER GASTROINTESTINAL BLEEDING IN PATIENTS WITH CANCER

    by Matheus C. Franco, Sunguk Jang, Bruno Martins, Tyler Stevens, Vipul Jairath, Rocio Lopez, John J. Vargo, Alan N. Barkun, Fauze Maluf-Filho

  • COMPARAÇÃO ENTRE OS ESCORES DE GLASGOW-BLATCHFORD, ROCKALL E AIMS65 PARA PREDIÇÃO DE DESFECHOS NOS PACIENTES COM CÂNCER E HEMORRAGIA DIGESTIVA ALTA

    by Matheus Franco, Bruno Martins, Sunguk Jang, Tyler Stevens, Rocio Lopez, Fabio Kawaguti, Ricardo Uemura, Carla Gusmon, Gustavo Paula, Elisa Baba, et al.

  • Open Access

    Compilation of curvilinear-array EUS imaging demonstrating variant pancreatic ductal anatomy with radiologic corroboration and motion animation

    by Matheus Cavalcante Franco, Abhik Bhattacharya, Amit Bhatt, Prabhleen Chahal


  • Transgastric retrograde endoscopic ultrasound sampling of a mediastinal mass in a patient with radiation-induced trismus

    by Matheus C. Franco, Andrew T. Strong, Prabhleen Chahal, Joseph Veniero, Brian Burkey, John J. Vargo, Amit Bhatt

    Endoscopic ultrasound (EUS) guidance is a safe and effective technique for sampling mediastinal lesions [1] [2] [3]. We report a case where an EUS was done in retrograde fashion through a gastrostomy because of the patient’s limited degree of mouth opening due to trismus. We present the case of a 42-year-old man with oropharyngeal squamous cell carcinoma (SCC) who had had a suboptimal response to chemoradiation and was therefore undergoing evaluation for surgery. A positron emission tomography (PET) scan showed a hypermetabolic mediastinal lesion. If this mediastinal lesion was a metastatic focus, the patient would not benefit from surgery and therefore sampling was required. An initial EUS-guided fine needle aspiration (FNA) failed as the echoendoscope could not be passed through the patient’s mouth because of his radiation-induced trismus. After multidisciplinary discussion, we proceeded with retrograde EUS-FNA of the mediastinal mass performed through the patient’s pre-existing gastrostomy ([Video 1]). Video 1 Video demonstrating retrograde endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) through an existing gastrostomy for sampling of a mediastinal mass in a patient with radiation-induced trismus. The procedure was performed with the patient under general anesthesia. The existing gastrostomy tube was removed and, after serial dilation of the gastrostomy tract, was replaced with a 15-mm laparoscopic trocar. A standard gastroscope was passed through the trocar and two hemoclips were placed in the gastric cardia to aid identification of the gastroesophageal junction (GEJ) during echoendoscope passage. A radial echoendoscope (GF-UE160-AL5; Olympus, Tokyo, Japan) was inserted through the trocar and advanced in retrograde fashion through the GEJ until the mediastinal mass was identified ([Fig. 1]). The radial echoendoscope was then exchanged for a linear echoendoscope (UC140P-AL5; Olympus) to perform the EUS-FNA ([Fig. 2]). Two passes with a 22G needle were diagnostic for carcinoma by on-site cytology. The linear echoendoscope and trocar were removed and a balloon-type gastrostomy tube was placed. Final pathology confirmed metastasis of the SCC. The patient was discharged on the same day without complications and was later started on palliative immunotherapy. Retrograde EUS-FNA through a gastrostomy for mediastinal mass sampling seems to be safe and feasible, and offers a novel solution for patients in whom the antegrade route is not available. Endoscopy_UCTN_Code_TTT_1AS